MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$259,140K
Cash and cash
equivalents
$134,930K
Accounts receivable, net
$37,996K
Inventory, net
$32,754K
Collaboration receivable, net
$23,745K
Short-term deposits
$19,616K
Prepaid expenses and
other current assets
$13,496K
Other receivables,
net
$6,404K
Property and equipment,
gross
$606K
Total current assets
$528,081K
Right-of-use asset
$1,342K
Property and equipment,
net
$181K
Restricted cash
$102K
Accumulated depreciation
$425K
Total assets
$529,706K
Total liabilities and
stockholders' equity
$529,706K
Total liabilities
$465,076K
Total stockholders'
equity
$64,630K
Accumulated deficit
-$1,506,580K
Total long-term
liabilities
$344,960K
Total current
liabilities
$120,116K
Additional paid-in capital
$1,570,749K
Accumulated other
comprehensive income
$452K
Common stock, 0.0001
par value,...
$9K
Royalty interest
financing, less current...
$343,909K
Right-of-use liability, less
current portion
$1,051K
Accrued expenses and
other current...
$103,064K
Accounts payable
$16,580K
Current portion of
right-of-use liability
$470K
Current portion of
capital lease
$2K
Back
Back
Balance Sheet
source: myfinsight.com
Syndax Pharmaceuticals Inc (SNDX)
Syndax Pharmaceuticals Inc (SNDX)